This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caviedes, L.
Right arrow Articles by Gilman, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caviedes, L.
Right arrow Articles by Gilman, R. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2002, p. 1873-1874, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1873-1874.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Tetrazolium Microplate Assay as a Rapid and Inexpensive Colorimetric Method for Determination of Antibiotic Susceptibility of Mycobacterium tuberculosis

Luz Caviedes,1 Jose Delgado,2 and Robert H. Gilman3*

Infectious Diseases Laboratory, Pathology Department, Universidad Peruana Cayetano Heredia,1 Asociación Benéfica PRISMA, Lima, Peru,2 Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland3

Received 24 October 2001/ Returned for modification 4 December 2001/ Accepted 12 February 2002


arrow
ABSTRACT
 
The emergence of multidrug-resistant tuberculosis underscores the need for low-cost, rapid methods to determine the susceptibility of Mycobacterium tuberculosis to antibiotics. A new, rapid, easily read, and inexpensive colorimetric method with a tetrazolium indicator performs this determination as quickly and accurately as the more expensive Alamar Blue technique.


arrow
TEXT
 
In recent years, tuberculosis (TB) has acquired a growing importance in developed and developing countries. The great toll of the disease, the emergence of multidrug-resistant (MDR) strains around the globe, and the close relationship between TB and human immunodeficiency virus infection underscore the need for simple, rapid, and affordable methods of detection and antibiotic susceptibility determination (2, 3, 5). Such methods could reduce the spread of resistant strains by determining more appropriate treatment regimens.

A rapid and low-cost method for the culture of Mycobacterium tuberculosis in clinical samples and determination of the susceptibilities of the strains to antibiotics was developed previously (1). This method, the microplate Alamar Blue assay (MABA), is based on the detection of colorimetric changes caused by the oxidation and reduction capabilities of Alamar Blue dye. With a pure culture, this method can determine antibiotic susceptibility in 6 to 7 days. We have recently tested a tetrazolium microplate assay (TEMA) that uses tetrazolium bromide [3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl-tetrazolium bromide] as an alternative, less expensive, and easier-to-read method for antibiotic susceptibility determination. This paper compares the results of this alternative method with those of the previously described MABA (1).

Briefly, the MABA involves the addition of Alamar Blue solution to microplates containing antibiotics in increasing concentrations and pure cultures of M. tuberculosis obtained from clinical samples. After an incubation period of 5 days, the growth of M. tuberculosis can be observed as a change in the coloration of the Alamar Blue solution due to reduction of the dye. MICs of each antibiotic tested can be determined by this change of color in the wells.

To perform the TEMA, suspensions of M. tuberculosis were prepared by emulsifying growth from slants with 100 µl of Tween 80 into 0.2% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.). The turbidity was adjusted to McFarland standard no. 1 (approximately 3 x 107 CFU/ml) by adding Tween 80 and bovine serum albumin. Three hundred microliters of bacterial suspension was further transferred to 7.2 ml of 7H9GC broth (4.7 g of Middlebrook 7H9 broth base [Difco, Detroit, Mich.], 20 ml of 10% glycerol, 1 g of Bacto Casitone [Difco], 880 ml of distilled water, 100 ml [each] of oleic acid, albumin, dextrose, and catalase [Remel, Lenexa, Kans.]).

Antibiotic dilutions and 96-well plates (Falcon 3072; Becton Dickinson, Lincoln Park, N.J.) were prepared as previously described for MABA (1). Briefly, 200 µl of sterile water was added to all outer wells. Portions (100 µl each) of 7H9GC broth were added to columns 3 to 11 in rows B to G (labeled as commercially stamped on the plates). One-hundred-microliter aliquots of 2x antibiotic solutions (isoniazid [INH], rifampin [RIF], streptomycin [STR], and ethambutol [ETB]) were added to the wells in columns 2 and 3. One hundred microliters of solution was transferred from column 3 to column 4 with a multichannel pipette. The antibiotics were serially diluted 1:2 in consecutive columns, except for column 10, where 100 µl of excess medium was discarded. The final drug concentration ranges were as follows: 0.125 to 32 µg/ml for INH, 0.062 to 16 µg/ml for RIF, 0.125 to 32 µg/ml for STR, and 0.5 to 128 µg/ml for ETB.

One hundred microliters of a log-phase M. tuberculosis bacterial suspension (20 to 30 days old) was added to wells in rows B to G in columns 2 to 11 with an Eppendorf repeating pipette. The wells in column 11 served as inoculum-only controls.

The plates were sealed with Parafilm and then incubated at 37°C for 5 days. On day 5, 50 µl of the tetrazolium-Tween 80 mixture {1.5 ml of tetrazolium [3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl-tetrazolium bromide] [Aldrich Chemical Co., Milwaukee, Wis.] at a dilution of 1 mg/ml in absolute ethanol and 1.5 ml of 10% Tween 80} was added to well B11 and the plate was then incubated at 37°C for 24 h. If well B11 turned purple, tetrazolium-Tween 80 was added to all wells and the color was recorded at 24 h. If well B11 remained yellow, the plates were incubated for another 24 h, after which tetrazolium-Tween 80 solution was added to well C11 before the plate was incubated for another 24 h. If well C11 remained yellow, incubation was continued and tetrazolium-Tween 80 solution was added to wells D11, E11, F11, and G11 on days 9, 11, 13, and 15, respectively.

Thirty-five sputum samples that tested positive for M. tuberculosis were obtained from patients at Cayetano Heredia Hospital in Lima, Peru, and processed by MABA and TEMA. All plates were read the first day after incubation with tetrazolium or Alamar Blue solution. The antibiotic susceptibility results are summarized in Table 1. Major agreement between the MABA and TEMA results was found for the INH and RIF MICs. On the other hand, some discordance appeared in the data on ETB susceptibility in resistant and partially resistant strains.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Results of and agreement between MABA and TEMA

The TEMA developed by our group has proven to be a reliable method for the determination of MDR strains of M. tuberculosis. The procedure is faster than other tetrazolium-based methods (4), because it uses ethanol instead of a lysis buffer, thus eliminating one step and shortening the total testing time by 1 day. At the same time, the method replaces Alamar Blue with an inexpensive tetrazolium indicator, thus reducing the cost compared to that of the previously developed MABA. The use of TEMA for the determination of susceptibilities to antibiotics (INH, RIF, STR, and ETB) costs 5.04 U.S. dollars for each strain tested compared to 7.54 U.S. dollars for each strain tested by MABA. These characteristics make the TEMA a promising alternative method for use in developing countries, where tuberculosis is an important and often fatal disease. An easy, rapid, and cheap assay could help to reduce the transmission of MDRTB by increasing the detection capacities of local laboratories and improving treatment regimens, thus reducing the amount of time patients remain contagious.


arrow
ACKNOWLEDGMENTS
 
This paper was partially supported by NIH-Fogarty training grant ITREID and USAID TB grant no. HRN-5986-A-00-6006-00.

We thank J. B. Phu, D. Sara, and C. Anderton for their technical assistance.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of International Health, Johns Hopkins School of Public Health, 615 N. Wolfe St., Room 3501, Baltimore, MD 21205. Phone: (410) 614-3639. Fax: (410) 614-6060. E-mail: rgilman{at}jhsph.edu. Back


arrow
REFERENCES
 
    1
  1. Franzblau, S. G., R. S. Witzig, J. C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M. T. Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson, and R. H. Gilman. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.[Abstract/Free Full Text]
  2. 2
  3. Havlir, D. V., and P. F. Barnes. 1999. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 340:367-373.[Free Full Text]
  4. 3
  5. Msamanga, G. I., and W. W. Fawzi. 1997. The double burden of HIV infection and tuberculosis in sub-Saharan Africa. N. Engl. J. Med. 337:849-851.[Free Full Text]
  6. 4
  7. Mshana, R. N., G. Tadesse, G. Abate, and H. Miörner. 1998. Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 36:1214-1219.[Abstract/Free Full Text]
  8. 5
  9. World Health Organization. 2001. Global tuberculosis control. WHO Report 2001. WHO/CDS/TB/2001.287. World Health Organization, Geneva, Switzerland.


Journal of Clinical Microbiology, May 2002, p. 1873-1874, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1873-1874.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Grandjean, L., Martin, L., Gilman, R. H., Valencia, T., Herrera, B., Quino, W., Ramos, E., Rivero, M., Montoya, R., Escombe, A. R., Coleman, D., Mitchison, D., Evans, C. A. (2008). Tuberculosis Diagnosis and Multidrug Resistance Testing by Direct Sputum Culture in Selective Broth without Decontamination or Centrifugation. J. Clin. Microbiol. 46: 2339-2344 [Abstract] [Full Text]  
  • Shiferaw, G., Woldeamanuel, Y., Gebeyehu, M., Girmachew, F., Demessie, D., Lemma, E. (2007). Evaluation of Microscopic Observation Drug Susceptibility Assay for Detection of Multidrug-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 45: 1093-1097 [Abstract] [Full Text]  
  • Martin, A., Portaels, F., Palomino, J. C. (2007). Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 59: 175-183 [Abstract] [Full Text]  
  • Mohammadzadeh, A., Farnia, P., Ghazvini, K., Behdani, M., Rashed, T., Ghanaat, J. (2006). Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis.. J Med Microbiol 55: 1657-1659 [Abstract] [Full Text]  
  • Kruuner, A., Yates, M. D., Drobniewski, F. A. (2006). Evaluation of MGIT 960-Based Antimicrobial Testing and Determination of Critical Concentrations of First- and Second-Line Antimicrobial Drugs with Drug-Resistant Clinical Strains of Mycobacterium tuberculosis.. J. Clin. Microbiol. 44: 811-818 [Abstract] [Full Text]  
  • Montoro, E., Lemus, D., Echemendia, M., Martin, A., Portaels, F., Palomino, J. C. (2005). Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 55: 500-505 [Abstract] [Full Text]  
  • Moore, D. A. J., Mendoza, D., Gilman, R. H, Evans, C. A. W., Hollm Delgado, M.-G., Guerra, J., Caviedes, L., Vargas, D., Ticona, E., Ortiz, J., Soto, G., Serpa, J., the Tuberculosis Working Group in Peru, (2004). Microscopic Observation Drug Susceptibility Assay, a Rapid, Reliable Diagnostic Test for Multidrug-Resistant Tuberculosis Suitable for Use in Resource-Poor Settings. J. Clin. Microbiol. 42: 4432-4437 [Abstract] [Full Text]  
  • Lemus, D., Martin, A., Montoro, E., Portaels, F., Palomino, J. C. (2004). Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 54: 130-133 [Abstract] [Full Text]  
  • Martin, A., Camacho, M., Portaels, F., Palomino, J. C. (2003). Resazurin Microtiter Assay Plate Testing of Mycobacterium tuberculosis Susceptibilities to Second-Line Drugs: Rapid, Simple, and Inexpensive Method. Antimicrob. Agents Chemother. 47: 3616-3619 [Abstract] [Full Text]  
  • Syre, H., Phyu, S., Sandven, P., Bjorvatn, B., Grewal, H. M. S. (2003). Rapid Colorimetric Method for Testing Susceptibility of Mycobacterium tuberculosis to Isoniazid and Rifampin in Liquid Cultures. J. Clin. Microbiol. 41: 5173-5177 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caviedes, L.
Right arrow Articles by Gilman, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caviedes, L.
Right arrow Articles by Gilman, R. H.